Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Dexamethasone vs Standard Prednisone in Newly Diagnosed ITP
NCT00657410Phase 3Completed
- Sponsor
- GIMEMA
- Start
- Apr 2008
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in immune thrombocytopenic purpura (ITP) (2 arms), sponsored by GIMEMA. Primary endpoint: Final response (complete, partial, and minimal response) rate. Started Apr 2008; status: completed.
02
Drugs
dexamethasone
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT00657410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657410.